Novo Nordisk A/SPembelian
NOVO - 23% weight loss causes 23% price drop
Head and Shoulders pattern complete, price drops from $148 to sub $80.
The drop from the head of the pattern is 23%, we should now be in Wave 5 where the final drop is 23%.
Cagrisema fat loss is 23% (below expectation of 25%). Wall St trims 23% off the stock price.
Largest sell volume seen in the stock, going into the oversold territory - 19 RSI on Daily, most oversold it's been in over a decade.
Possible support from the following confluence:
200 Week EMA, Golden Fibonacci pocket 0.618, possible end of 5th wave.
Time to DCA, from $78 down to $58, for a 3-5 year hold.
Not financial advice
The drop from the head of the pattern is 23%, we should now be in Wave 5 where the final drop is 23%.
Cagrisema fat loss is 23% (below expectation of 25%). Wall St trims 23% off the stock price.
Largest sell volume seen in the stock, going into the oversold territory - 19 RSI on Daily, most oversold it's been in over a decade.
Possible support from the following confluence:
200 Week EMA, Golden Fibonacci pocket 0.618, possible end of 5th wave.
Time to DCA, from $78 down to $58, for a 3-5 year hold.
Not financial advice
Publikasi terkait
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.